Concepedia

Author

Kenichiro Kodama

Hiroshima University

Also Known As

K. Kodama, Kenichiro Kodama, Kodama, Kenichiro

46

Publications

697

Citations

16

H-Index

20

Concepts

All Affiliations

Hiroshima UniversityHiroshima University HospitalRIKEN Center for Integrative Medical SciencesChugoku Rosai HospitalHiroshima City Asa Citizens Hospital
KK

About

Kenichiro Kodama is an author at Hiroshima University specializing in medicine, hepatology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

79

2

Hepatology

4

4

79

3

Health Sciences

3

3

57

4

Pathology

2

2

34

5

Immunology

1

1

22

Kenichiro Kodama

×

20

Publications

635

Citations

16

H-Index

YearCitations

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis

Akira Hiramatsu, Hiroshi Aikata, Shinsuke Uchikawa,

Hepatology Communications

2019

60

Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib

Kenichiro Kodama, Tomokazu Kawaoka, Maiko Namba,

Oncology

2019

57

Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

Masami Yamauchi, Atsushi Ono, Akira Ishikawa,

Clinical and Translational Gastroenterology

2020

55

Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis

Kenichiro Kodama, Tomokazu Kawaoka, Hiroshi Aikata,

Oncology

2018

48

Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real‐world practice

Shinsuke Uchikawa, Tomokazu Kawaoka, Hiroshi Aikata,

Hepatology Research

2018

46

Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib

Yasutoshi Fujii, Atsushi Ono, C. Nelson Hayes,

Journal of Experimental & Clinical Cancer Research

2021

44

Skeletal Muscle Loss during Tyrosine Kinase Inhibitor Treatment for Advanced Hepatocellular Carcinoma Patients

Shinsuke Uchikawa, Tomokazu Kawaoka, Maiko Namba,

Liver Cancer

2019

43

Early Tumor Response and Safety of Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma in Real-World Practice

Yuwa Ando, Tomokazu Kawaoka, Masanari Kosaka,

Cancers

2021

41

Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status

Kenichiro Kodama, Tomokazu Kawaoka, Hiroshi Aikata,

Journal of Gastroenterology and Hepatology

2018

39

Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib

Yuwa Ando, Tomokazu Kawaoka, Yosuke Suehiro,

Oncology

2020

31

Page 1